- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Fredun Pharmaceuticals Ltd (FRED)
Fredun Pharmaceuticals Ltd stock price live, this page displays BO FRED stock exchange data. View the FRED premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Fredun Pharmaceuticals Ltd real time stock price chart below.
What Is the Fredun Pharmaceuticals Ltd Stock Price Today?
The Fredun Pharmaceuticals Ltd stock price today is 1,435.15.
What Is the Stock Symbol for Fredun Pharmaceuticals Ltd?
The stock symbol for Fredun Pharmaceuticals Ltd is "FRED."
What Stock Exchange Does Fredun Pharmaceuticals Ltd Trade On?
Fredun Pharmaceuticals Ltd is listed and trades on the BSE stock exchange.
Is Fredun Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Fredun Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the FRED quote. (ISIN: INE194R01017)
What Is the Fredun Pharmaceuticals Ltd Stock Price Today?
The Fredun Pharmaceuticals Ltd stock price today is 1,435.15.
What Is the Stock Symbol for Fredun Pharmaceuticals Ltd?
The stock symbol for Fredun Pharmaceuticals Ltd is "FRED."
What Stock Exchange Does Fredun Pharmaceuticals Ltd Trade On?
Fredun Pharmaceuticals Ltd is listed and trades on the BSE stock exchange.
Is Fredun Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Fredun Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the FRED quote. (ISIN: INE194R01017)
1,435.15
-36.35(-2.47%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,415.40
1,475.60
52 wk Range
376.67
1,600.00
FRED is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,415.401,475.60
52 wk Range
376.671,600.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.02%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.02%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
FRED Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high P/E ratio relative to near-term earnings growth
- Fredonia Mining Inc. Announces Consolidation Details
- Investing.com
- Fredonia Mining Inc. Announces Consolidation Details
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Strong Buy
Fredun Pharmaceuticals Ltd Earnings Call Summary for Q1/2027
- Fredun Pharmaceuticals Q1 FY27 revenue surged 90% YoY to INR 228.25 crores; net profit rose 95% to INR 13.17 crores; shares jumped 10%.
- Company targets blended revenue growth of 30-35% over next three years, driven by new-age brands growing 35-45% and vintage business at 15-20%.
- Management expects EBIT margins to reach 12-13% within 12 quarters, with profitability spike anticipated in 8-11 quarters from geographic expansion.
- FY27 revenue guidance set at INR 800 crores with expected overachievement; CapEx planned at INR 30-40 crores for FY27 and following year.
- InvestingPro analysis flags stock as overvalued at current levels despite strong growth; working capital at INR 170-175 crores against INR 850 crores base.
Last Updated: 08/13/2026, 03:18 PM
Read Full TranscriptEarnings
Latest Release
May 25, 2026
EPS / Forecast
18.22 / --
Revenue / Forecast
2.13B / --
Compare FRED to Peers and Sector
Metrics to compare | FRED | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipFREDPeersSector | |
|---|---|---|---|---|
P/E Ratio | 60.9x | 34.5x | −0.4x | |
PEG Ratio | 1.57 | 0.88 | 0.00 | |
Price/Book | 8.5x | 4.8x | 2.6x | |
Price / LTM Sales | 3.2x | 3.8x | 3.1x | |
Upside (Analyst Target) | - | 7.7% | 48.9% | |
Fair Value Upside | Unlock | 3.6% | 6.2% | Unlock |
Fredun Pharmaceuticals Limited manufactures and sells pharmaceutical formulations, dietary/herbal supplements, nutraceuticals, animal healthcare products, cosmeceuticals, mobility and rehabilitation products, and other healthcare products in India, Africa, Southeast Asia, Commonwealth of Independent States countries, MENA region, and Latin America. The company offers allopathic formulations, including analgesics/NSAID, antacid/antiulcer, anthelmintic, antibacterial, anti-diabetic, anti-inflammatory, anti-malarial, anti-obesity, antacid, anthelmintic, anticoagulants, anticonvulsants, antidiarrhoeal, antidepressant, antifungal, antihistamines/antiallergic, antihypertensives, antiviral, bone modulating drugs, bronchodilators and anti-asthma drugs, calcium tablets, cardiovascular, diuretic, impotence drugs, laxative, and appetite stimulant with multivitamins. It also provides surgical products, such as IV fluids and cannulas, disposable syringes, infusion sets, surgical gloves and cottons, and personal healthcare products; APIs; direct compressible granules; pellets; animal healthcare products; aqua products; and niche products. Additionally, the company offers therapeutic products under the brand Hormone Range Products, a specialty therapeutics brand focused on longevity, hormone health, recovery science, and human performance solutions. Fredun Pharmaceuticals Limited was incorporated in 1987 and is headquartered in Mumbai, India.,
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Fredun Pharmaceuticals (FRED) Stock Price Today?
The Fredun Pharmaceuticals stock price today is 1,435.15 INR.
What Stock Exchange Does Fredun Pharmaceuticals Trade On?
Fredun Pharmaceuticals is listed and trades on the Bombay Stock Exchange.
What Is the Stock Symbol for Fredun Pharmaceuticals?
The stock symbol for Fredun Pharmaceuticals is "FRED."
Does Fredun Pharmaceuticals Pay Dividends? What’s The Current Dividend Yield?
The Fredun Pharmaceuticals dividend yield is 0.02%.
What Is the Fredun Pharmaceuticals Market Cap?
As of today, Fredun Pharmaceuticals market cap is 23.73B INR.
What Is Fredun Pharmaceuticals's Earnings Per Share (TTM)?
The Fredun Pharmaceuticals EPS (TTM) is 23.48.
From a Technical Analysis Perspective, Is FRED a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Fredun Pharmaceuticals Stock Split?
Fredun Pharmaceuticals has split 1 times.
How Many Employees Does Fredun Pharmaceuticals Have?
Fredun Pharmaceuticals has 736 employees.
What is the current trading status of Fredun Pharmaceuticals (FRED)?
As of Aug 23, 2026, Fredun Pharmaceuticals (FRED) is trading at a price of 1,435.15 INR, with a previous close of 1,471.50 INR. The stock has fluctuated within a day range of 1,415.40 INR to 1,475.60 INR, while its 52-week range spans from 376.67 INR to 1,600.00 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.